Clinical Trial to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/Nesolicaftor in Adults With CF

Clinical trial NCT06468527 · COMPLETED

Trial details

NCT number: NCT06468527
Sponsor: Kors van der Ent
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2024-06-03
Primary completion: 2025-06-26
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.